MD3 CHANGES IN BODYWEIGHT AND ASSOCIATED DOSING REQUIREMENTS FOR RHEUMATOID ARTHRITIS PATIENTS RECEIVING INFLIXIMAB—RESULTS FROM ANALYSIS OFTHE BRITISH SOCETY FOR RHEUMATOLOGY'S BIOLOGICS REGISTER (BSRBR)
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)64898-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)64898-X/fulltext
Section Title :
Section Order :
57
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64898-X&doi=10.1016/S1098-3015(10)64898-X